SEC
SlamSEC
Search
Browse
Earnings
CytoDyn Inc. — SlamSEC
CytoDyn Inc.
OTC:
CYDY
Pharmaceutical Preparations
·
VANCOUVER, WA
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
Revenue
$266,000
FY 2023
Adj. EBITDA
-$18.0M
-6777.8% margin
FY 2025
Net Income
-$49.8M
-18737.2% margin
FY 2025
EPS (Diluted)
-$0.05
FY 2025
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$3.1M
FY 2025
Total Debt
$2.3M
FY 2015
Net Cash
$771,316
FY 2015
Enterprise Value
—
Debt / EBITDA
0.0x
FY 2023
EV / EBITDA
—
Employees
—
CEO
Lalezari Jacob P
CFO
Hoffman Robert E.